Application

16110597 · Methods of treatment using activatable anti-EGFR antibodies

Filed 2018-08-23 · Granted · Patent 10875913 (2020-12-29) The official file ↗The patent and its PDF ↗ · Art unit 1647 · Examiner Elly Gerald Stoica Typical · CPC C07K 16/22 · CytomX Therapeutics, Inc. · CytomX/Rothwell Figg

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

13.3 mo

to disposition 28.2 mo

Statutes raised

112 DP

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.